REAADS II ANTI-CARDIOLIPIN IGG SEMI-QUANTITATIVE TEST KIT, MODEL 11139— 510(k) K032868
Substantially EquivalentCorgenix, Inc.
FDA 510(k) clearance K032868 for REAADS II ANTI-CARDIOLIPIN IGG SEMI-QUANTITATIVE TEST KIT, MODEL 11139, Substantially Equivalent on 2003-10-14. Applicant: Corgenix, Inc..
Clearance details
- Applicant
- Corgenix, Inc.
- Product code
- Code MID
- Advisory panel
- Immunology
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Special
- Location
- Westminster, CO, US
Data sourced from openFDA. This site is unofficial and independent of the FDA.